PHAIM PHARMA LTD
Company number 09355572 · Active · London WC2B 5AH
PHAIM PHARMA LTD is an active private limited company (company number 09355572) incorporated on 15 December 2014, registered in London. Its registered activity is research and experimental development on biotechnology (SIC 72110). Latest small accounts cover the period ending 30 June 2025, showing net assets of −£911k and cash of £98, with 0 employees on average. Net assets fell 15% on the prior period (−£791k).
By net assets it sits in the bottom quarter of 603 comparable companies in London (median £440, upper quartile £92k).
Key dates
- Incorporated
- 15 December 2014
- Next accounts due
- 30 March 2027 — in 159 days
- Confirmation statement due
- 29 December 2026 — in 68 days
Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.
Activity
- SIC 72110
- Research and experimental development on biotechnology
- Accounts type
- Total Exemption Full
- Size band
- Micro (Companies Act thresholds)
Financials — 2 periods on record, latest ending 30 June 2025
| Period end | Net assets | Cash | Debtors | Creditors <1y | Turnover | Profit | Employees |
|---|---|---|---|---|---|---|---|
| 30 June 2025 | −£911k | £98 | — | £930k | — | — | 0 |
| 30 June 2024 | −£791k | £98 | — | £858k | — | — | 1 |
- Current ratio
- 0.02 — current liabilities exceed current assets
Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.
Firmoscan score: 35/100 (grade D)
- -15 Negative net assets — Net assets £-911,096 at 2025-06-30
- -8 Current liabilities exceed current assets — Current ratio 0.02
- +8 Established — Incorporated 2014-12-15 (12 years)
A transparent, rules-based score from filed data only: every point lists its evidence. It is not a credit rating or advice.
Ownership and control
- Dr Hiam Orban Nee Jalahey — has significant influence or control · since 6 April 2016
- Dr Tihamer Orban — owns 25–50% of shares · since 6 April 2016
- Prof Piers Edward Francis Daubeney — has significant influence or control · since 6 April 2016
- Dr Nara Daubeney — has significant influence or control · since 6 April 2016
Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents.
Similar companies in London
Same activity (research and experimental development on biotechnology), closest in incorporation date.
- PROTLAB GPL LIMITED — London, inc. Dec 2014
- ORTHONIKA LIMITED — London, inc. Dec 2014
- TEEGENE BIOTECH LIMITED — London, inc. Dec 2014
- MEIRAGTX UK II LIMITED — London, inc. Dec 2014
- DUCHENNE RESEARCH (UK) INVESTMENT LIMITED — London, inc. Dec 2014
- DERJACQUES LIMITED — London, inc. Dec 2014
All companies incorporated on 15 December 2014 · in Dec 2014.
Reminders for PHAIM PHARMA LTD
Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.